MONDAY, May 23, 2022 (HealthDay News) — Americans with sickle cell disease who have private insurance face average out-of-pocket costs of $1,300 a year and a lifetime total of $44,000, new research reveals. That means that their out-of-pocket expenses are nearly four times higher compared to people without the inheritedContinue Reading

WEDNESDAY, April 27, 2022 (HealthDay News) — People with sickle cell disease who take corticosteroids to treat asthma or inflammation may suffer severe pain and even need to be hospitalized, researchers report. This reaction to corticosteroids can be particularly severe among older people, women and patients not taking the drugContinue Reading

FRIDAY, April 15, 2022 (HealthDay News) — Cancer patients’ blood type may play a role in their risk for dangerous blood clots, researchers say. Cancer and its treatments increase the risk for venous thromboembolism (VTE). That includes deep-vein thrombosis (DVT, a blood clot that typically forms in the deep veinsContinue Reading

THURSDAY, April 7, 2022 (HealthDay News) — COVID-19 increases people’s risk of dangerous blood clots and bleeding for months after infection, researchers say. The new findings suggest that COVID-19 is an independent risk factor for deep vein thrombosis, pulmonary embolism and bleeding. “Our findings arguably support [treatment] to avoid thromboticContinue Reading

FRIDAY, Feb. 18, 2022 (HealthDay News) — “Rogue antibodies” that seem to trigger severe blood clotting and illness in COVID-19 patients have been identified by scientists. Their analysis of blood samples from 244 patients hospitalized for COVID-19 revealed circulating antiphospholipid antibodies, which are autoantibodies that target a person’s own organsContinue Reading

THURSDAY, Feb. 3, 2022 (HealthDay News) — A newer type of “clot-busting” medication might be safer than the one long used for treating strokes, a preliminary study hints. Researchers found that among nearly 7,900 stroke sufferers, those treated with the drug — called tenecteplase — were less likely to sufferContinue Reading